The Food and Drug Administration approved the Makena subcutaneous auto injector that was developed by AMAG Pharmaceuticals Inc. (Nasdaq: AMAG) and Antares Pharma Inc. (Nasdaq: ATRS). Shares of AMAG Pharmaceuticals leaped $4.05 to close at $17.95 while Antares Pharma stock climbed 37 cents to close at $2.35.
FDA approves AMAG's and Antares' injector
February 15, 2018 at 16:02 PM EST
